ArticleCureus2026

Severe Dermatologic Toxicity During Amivantamab-Lazertinib Treatment in Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer.

Chloe M Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.